ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market
Holding ADMA?
Track your performance easily

ADMA Biologics (ADMA) Ownership - Who Owns ADMA Biologics?

2,703 Followers

ADMA Biologics (ADMA) Ownership Overview

3.60%19.73%3.79%28.63%44.25%
3.79% Other Institutional Investors
28.63% ETFs
44.25% Public Companies and Individual Investors
The ownership structure of ADMA Biologics (ADMA) stock is a mix of institutional, retail, and individual investors. Approximately 52.15% of the company’s stock is owned by Institutional Investors, 3.60% is owned by Insiders, and 44.25% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 11, 2024
xxxxxxxxxxxxx
$166140
Aug 30, 2024
xxxxxxxxxxxxx
$2363589
Aug 27, 2024
Adam Grossman
President & Ceo,director
xxxxxxxxxxxxx
$4190566
Aug 27, 2024
Young Kwon
Director
xxxxxxxxxxxxx
$1095600

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
28,189,058Institution12.09%637,636,492
13,914,869Institution5.97%314,754,337
10,613,636Institution4.55%240,080,446
10,027,448Institution4.30%226,820,874
7,967,585Institution3.42%180,226,773
4,665,156Institution2.00%105,525,829
3,762,357Insider1.61%85,104,515
2,772,955Institution1.19%62,724,242
2,559,088Institution1.10%57,886,571
2,289,582Institution0.98%51,790,345

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
10,027,448Institution4.30%226,820,874
4,665,156Institution2.00%105,525,829
2,772,955Institution1.19%62,724,242
2,559,088Institution1.10%57,886,571
2,289,582Institution0.98%51,790,345
2,211,226Institution0.95%50,017,932
2,202,551Institution0.94%49,821,704
1,829,510Institution0.78%41,383,516
1,510,790Institution0.65%34,174,070
1,501,503Institution0.64%33,963,998

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
14,861,703Institution6.38%336,171,722
7,152,564Institution3.07%142,979,754
6,139,914Institution2.63%138,884,855
4,408,472Institution1.89%86,935,068
3,460,780Institution1.48%69,180,992
3,147,619Institution1.35%62,071,047
3,147,619Institution1.35%62,071,047
3,147,619Institution1.35%62,071,047
2,259,998Institution0.97%51,121,155
2,026,329Institution0.87%45,835,562

FAQ

Who Owns ADMA Biologics (ADMA)?
According to the latest TipRanks data, approximately 3.79% of the company's stock is held by institutional investors, 3.60% is held by insiders, and 44.25% is held by retail investors.
    What percentage of ADMA Biologics (ADMA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.79% of ADMA Biologics (ADMA) stock is held by institutional investors.
      What percentage of ADMA Biologics (ADMA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 44.25% of ADMA Biologics (ADMA) stock is held by retail investors.
        Who owns the most shares of ADMA Biologics (ADMA)?
        iShares owns the most shares of ADMA Biologics (ADMA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis